Health care systems such as Kaiser Permanente have seen a “leveling off” of COVID-19 cases, with hospital admissions to the ICU more manageable compared to two weeks ago.
The Coalition of Kaiser Permanente Unions said it reached an agreement with the health care giant.
During the COVID-19 outbreak, Kaiser Permanente has temporarily closed select medical offices while others will limit services in an effort to control exposure to the virus.
Simulations Plus has acquired French medical software company Lixoft, further expanding its drug simulation capabilities and broadening its presence in Europe.
Amgen Inc. and Seattle-based Adaptive Biotechnologies on Thursday announced a strategic partnership to discover and develop a treatment for COVID-19.
Amgen Inc. has purchased 49 percent of shares for Amgen Astellas BioPharma, the result of a 2013 joint venture between Japanese company Astellas Pharma and the Thousand Oaks biotech giant. Financial terms of buyout were not disclosed.
Second Sight Medical Products Inc. on Monday announced it will lay off 84 of its 108 employees effective March 31 in response to COVID-19 challenges, the first step toward the end of the Sylmar company.
Biotech follows different paths with Conejo Valley startups pursuing new drugs and Santa Clarita companies focused on medical devices.
Simulations Plus is fast tracking its consulting services for businesses working on coronavirus research.
Valley health care providers are preparing for patients who need the test for the coronavirus.
Hospitals in the Valley region are preparing for an influx of COVID-19 patients, with experts predicting many facilities in the U.S. health care system will be overwhelmed with cases in the coming months.
At least 38 cases of coronavirus have been confirmed in the San Fernando Valley area.
Ventura County has ordered certain businesses to close and elderly residents to stay at home to slow the spread of coronavirus, effective Wednesday.
MannKind Corp. on Tuesday announced it is adjusting its pipeline research to focus on respiratory viral infections such as coronavirus.
Second Sight Medical Products Inc. announced Thursday the departure of Chief Executive Will McGuire, effective March 27.